Wei Meng

3PUBLICATIONS
7CO-AUTHORS
Biologically active moleculesBasic pharmacology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Sep 19, 2023
Discovery of <b>12</b> (BMS-986172) as a Highly Potent MGAT2 Inhibitor that Achieved Targeted Efficacious Exposures at a Low Human Dose for the Treatment of Metabolic Disorders.

Wei Meng, Robert Brigance, James Mignone

|Feb 18, 2022
Discovery of a Partial Glucokinase Activator Clinical Candidate: Diethyl ((3-(3-((5-(Azetidine-1-carbonyl)pyrazin-2-yl)oxy)-5-isopropoxybenzamido)-1<i>H</i>-pyrazol-1-yl)methyl)phosphonate (BMS-820132).

Yan Shi, Ying Wang, Wei Meng

|Dec 02, 2021
Identification of a Hydroxypyrimidinone Compound (<b>21</b>) as a Potent APJ Receptor Agonist for the Potential Treatment of Heart Failure.

Wei Meng, Zulan Pi, Robert Brigance

Pageof 1

Frequent Collaborators

1 joint publications

Zulan Pi

1 joint publications

Heather J Finlay

1 joint publications

Yan Shi

1 joint publications

Bruce Ellsworth